Ultrasound-enhanced delivery of polymer-coated oncolytic adenovirus for tumour growth inhibition

Ultrasound-enhanced delivery of polymer-coated oncolytic adenovirus for tumour growth inhibition

Bibliographic Details
Main Authors:	Carlisle, R, Choi, J, Kostka, L, Bazan-Peregrino, M, Ulbrich, K, Coussios, C, Seymour, L
Format:	Journal article
Published:	2011

Similar Items

Cavitation-enhanced delivery of a replicating oncolytic adenovirus to tumors using focused ultrasound.
by: Bazan-Peregrino, M, et al.
Published: (2013)

Cavitation-enhanced delivery of a self-amplifying oncolytic adenovirus for tumour-selective cancer therapy.
by: Carlisle, R, et al.
Published: (2012)

Ultrasound-induced cavitation enhances the delivery and therapeutic efficacy of an oncolytic virus in an in vitro model
by: Bazan-Peregrino, M, et al.
Published: (2012)

Ultrasound-induced cavitation enhances the delivery and therapeutic efficacy of an oncolytic virus in an in vitro model.
by: Bazan-Peregrino, M, et al.
Published: (2012)

Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound.
by: Carlisle, R, et al.
Published: (2013)

Factors influencing retention of adenovirus within tumours following direct intratumoural injection.
by: Bazan-Peregrino, M, et al.
Published: (2008)

Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus.
by: Bazan-Peregrino, M, et al.
Published: (2008)

Coating of adenovirus type 5 with polymers containing quaternary amines prevents binding to blood components.
by: Subr, V, et al.
Published: (2009)

Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy.
by: Fisher, K, et al.
Published: (2007)

Increasing the density of nanomedicines improves their ultrasound-mediated delivery to tumours
by: Mo, S, et al.
Published: (2015)

Increased Adenovirus density for increased ultrasound-mediated delivery to tumors
by: Carlisle, R, et al.
Published: (2013)

Polymer coatings for delivery of nucleic acid therapeutics.
by: Laga, R, et al.
Published: (2012)

Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer.
by: Green, N, et al.
Published: (2012)

Polymer coatings for delivery of nucleic acid therapeutics
by: Laga, R, et al.
Published: (2012)

Ultrasound-enhanced drug delivery for cancer.
by: Mo, S, et al.
Published: (2012)

Coating of adenovirus type 5 with cleavable PEGylated gold nanoparticles for enhanced protection and circulation
by: Mo, S, et al.
Published: (2013)

Targeting adenovirus gene delivery to activated tumour-associated vasculature via endothelial selectins.
by: Bachtarzi, H, et al.
Published: (2011)

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
by: Fisher, K, et al.
Published: (2001)

Achieving systemic delivery of oncolytic viruses
by: Hill, C, et al.
Published: (2019)

Targeting polymer coated adenovirus to tumour-associated vasculature
by: Bachtarzi, H
Published: (2010)

Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus
by: Hill, C, et al.
Published: (2021)

Combining oncolytic adenovirus with radiation – a paradigm for the future of radiosensitization
by: O'Cathail, S, et al.
Published: (2017)

Bioprocessing of oncolytic group B adenovirus for scalable production
by: Cooper, L
Published: (2014)

Factors responsible for inhibition of adenovirus infection by cellular debris and tumour lysate
by: Tedcastle, A, et al.
Published: (2011)

Characterisation of a novel group B oncolytic adenovirus, ColoAd1
by: Di, Y, et al.
Published: (2011)

Use of synthetic vectors for neutralising antibody resistant delivery of replicating adenovirus DNA.
by: Carlisle, R, et al.
Published: (2006)

Cavitation-enhanced extravasation for drug delivery.
by: Arvanitis, C, et al.
Published: (2011)

Cavitation-Enhanced Extravasation for Drug Delivery
by: Arvanitis, C, et al.
Published: (2011)

Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
by: Mahasa, K, et al.
Published: (2020)

The effect of polymer coating and different adenovirus serotypes on the innate immune responses to intraperitoneal adenovirus
by: Thoma, C, et al.
Published: (2008)

Exploring the relationship between cancer metabolism and oncolytic adenoviruses
by: Dyer, A
Published: (2021)

Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
by: Freedman, J, et al.
Published: (2017)

Polymeric cups for cavitation mediated delivery of oncolytic vaccinia virus
by: Myers, R, et al.
Published: (2016)

Adenovirus type 5 interactions with human blood cells may compromise systemic delivery.
by: Lyons, M, et al.
Published: (2006)

Polymer-coated polyplexes designed for triggered activation utilising intracellular reduction
by: Briggs, S, et al.
Published: (2004)

Polymer-coated polyethylenimine/DNA complexes designed for triggered activation by intracellular reduction.
by: Carlisle, R, et al.
Published: (2004)

A Dynamical Systems Model for Combinatorial Cancer Therapy Enhances Oncolytic Adenovirus Efficacy by MEK-Inhibition
by: Bagheri, Nada, et al.
Published: (2011)

Exploring the interface between endoplasmic reticulum stress and oncolytic adenoviruses
by: Taverner, WK
Published: (2019)

Use of micro- and nano-sized inertial cavitation nuclei to trigger and map drug release from cavitation-sensitive liposomes.
by: Graham, S, et al.
Published: (2013)

Antagonism of glycolysis and reductive carboxylation of glutamine potentiates activity of oncolytic adenoviruses in cancer cells
by: Dyer, A, et al.
Published: (2018)